Syntheses of chlorpromazine undecahydrododecaborate and nonahydrodecaborate-promising agents for neutron capture therapy of malignant melanoma.

DOI Web Site PubMed

この論文をさがす

抄録

It has been suggested by dermatologists that boron compounds of chlorpromazine are promising agents for neutron capture therapy of malignant melanoma. The compounds are desired to have a high boron content, good stability, and sufficient solubility in water. To fulfil these requirements, chlorpromazine undecahydrododecaborate and nonahydrodecaborate have been synthesized starting from 2-chloro-10 (3-bromopropyl) phenothiazine and ammonioundecahydrododecaborate or 2-ammoniononahydrodecaborate, respectively.

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ